SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Questions & Answers — Understanding the Renin System

References

  • Azizi M., Webb R., Nussberger J. et al. Renin inhibition with aliskiren: where are we now, and where are we going? J Hypertens 2006;24:243-56.[Web of Science][Medline] [Order article via Infotrieve]
  • Nguyen G., Delarue F., Burcklé C. et al. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002;109:1417-27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ichihara A., Hayashi M., Kaneshiro Y. et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the `handle' region for nonproteolytic activation of prorenin. J Clin Invest 2004;114:1128-35.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Danser AHJ, van Kesteren CA, Bax WA et al. Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding. Circulation 1997;96:220-6.[Abstract/Free Full Text]
  • Deinum J., Ronn B., Mathiesen E. et al. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulindependent diabetes mellitus. Diabetologia 1999;42:1006-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Chiarelli F., Pomilio M., De Luca FA et al. Plasma prorenin levels may predict persistent microalbuminuria in children with diabetes. Pediatr Nephrol 2001;16:116-20.[CrossRef][Medline] [Order article via Infotrieve]
  • Deinum J., Tarnow L., van Gool JM et al. Plasma renin and prorenin and renin gene variation in patients with insulindependent diabetes mellitus and nephropathy. Nephrol Dial Transplant 1999;14:1904-11.[Abstract/Free Full Text]
  • Daneman D., Crompton CH, Balfe JW et al. Plasma prorenin as an early marker of nephropathy in diabetic (IDDM) adolescents. Kidney Int 1994;46:1154-9.[Web of Science][Medline] [Order article via Infotrieve]
  • Danser AH, van den Dorpel MA, Deinum J. et al. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab 1989; 68:160-7.[Abstract/Free Full Text]
  • Wilson DM, Luetscher JA Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med 1990;323:1101-6.[Abstract]
  • Yokota H., Mori F., Kai K. et al. Serum prorenin levels and diabetic retinopathy in type 2 diabetes: new method to measure serum level of prorenin using antibody activating direct kinetic assay. Br J Ophthalmol 2005;89:871-3.[Abstract/Free Full Text]
  • Singh HJ, Rahman A., Larmie ET et al. Raised prorenin and renin concentrations in pre-eclamptic placentae when measured after acid activation. Placenta 2004;25:631-6.[CrossRef][Medline] [Order article via Infotrieve]
  • Vrtacnik-Bokal E., Meden-Vrtovec H., Osredkar J. et al. Follicular fluid renin concentration in patients with polycystic ovaries treated with gonadotrophins in an in vitro fertilisation programme. Clin Chem Lab Med 2003;41:663-7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Giles TD, Berk BC, Black HR et al. Expanding the definition and classification of hypertension. J Clin Hypertens 2005;7:505-12.[CrossRef]
  • Ichihara A., Kaneshiro Y., Takemitsu T. et al. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006;47:894-900.[Abstract/Free Full Text]
  • Satofuka S., Ichihara A., Nagai N. et al. Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci 2006;47:2686-92.[Abstract/Free Full Text]
  • Feldt S., Batenburg WW, Mazak I. et al. Prorenin and renin-induced extracellular signal-regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension 2008;51:682-8.[Abstract/Free Full Text]
  • Feldt S., Maschke U., Dechend R. et al. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol 2008; 19:743-8.[Abstract/Free Full Text]
  • Burcklé CA, Jan Danser AH, Muller DN et al. Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 2006;47:552-6.[Abstract/Free Full Text]
  • Kaneshiro Y., Ichihara A., Sakoda M. et al. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol 2007;18:1789-95.[Abstract/Free Full Text]
  • Stankovic AR, Fisher ND, Hollenberg NK Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes. J Am Soc Nephrol 2006;17:3293-9.[Abstract/Free Full Text]
  • Kang JJ, Toma I., Sipos A. et al. The collecting duct is the major source of prorenin in diabetes. Hypertension 2008;51:1597-604.[Abstract/Free Full Text]
  • Siragy HM Renin inhibition: a new modality for hypertension management. Curr Hypertens Rep 2007;9:291-4.[Medline] [Order article via Infotrieve]
  • Price DA, Porter LE, Gordon M. et al. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 1999; 10:2382-91.[Abstract/Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 9, No. 4, 247-249 (2008)
DOI: 10.1177/14703203080090040902


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement